News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Civik Thomas
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/12/2023 |
4
| Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2022 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns:
| Granted 66,831 shares
@ $0 |
|
11/19/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns:
| Bought 15,700 shares
@ $12.74, valued at
$200k
|
|
11/18/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns:
| Bought 7,500 shares
@ $28.08, valued at
$210.6k
|
|
10/12/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.
Txns:
| Granted 42,191 options to buy
@ $16, valued at
$675.1k
|
|
09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2020 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns:
| Granted 75,000 shares
@ $0 Granted 480,000 options to buy
@ $2.72, valued at
$1.3M
|
|
08/02/2018 |
4
| Civik Thomas (Chief Commercial Officer) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Disposed of 33,421 shares
@ $137, valued at
$4.6M
|
|
01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|